Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Eikon Therapeutics, a star-studded biotechnology startup that raised more than $1 billion in venture funding, said Wednesday it has secured $381 million more through an initial public offering. The California biotech sold over 21 million shares at $18 apiece, far more than it initially set out to sell when it set terms for its offering last week. Shares will ...